6934.TWO
Price:
$73.6
Market Cap:
$2.41B
HCmed Innovations Co Ltd. provides platforms for inhalation therapy using mesh technology. Its products include Pulmogine and AdheResp. The firm offers comprehensive aerosol characterization analytical services to support the development and optimization of inhalation products. It also offers analytical support in compliance with Pharmacopoeia guidelines. The company was founded by Jason Cheng, Leon Tsai, Shaogi Huang and Simon Hsieh on October 06, 2014 and is headquartered in Taipei, Taiwan.
Industry
Biotechnology
IPO Date
2024-06-25
Stock Exchange
TWO
Ticker
6934.TWO
According to Hcmed’s latest financial reports and current stock price. The company's current PE Ratio is -19.37. This represents a change of -21.70% compared to the average of -24.74 of the last 4 quarters.
The mean historical PE Ratio of Hcmed over the last ten years is -22.42. The current -19.37 PE Ratio has changed 8.54% with respect to the historical average. Over the past ten years (40 quarters), 6934.TWO's PE Ratio was at its highest in in the December 2022 quarter at 0. The PE Ratio was at its lowest in in the December 2024 quarter at -61.62.
Average
-22.42
Median
-27.88
Minimum
-31.93
Maximum
-10.50
Discovering the peaks and valleys of Hcmed PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 183.89%
Maximum Annual PE Ratio = -10.50
Minimum Annual Increase = -65.61%
Minimum Annual PE Ratio = -31.93
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -31.93 | 183.89% |
| 2023 | -11.25 | 7.17% |
| 2022 | -10.50 | -65.61% |
| 2021 | -30.52 | 9.50% |
The current PE Ratio of Hcmed (6934.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-17.89
5-year avg
-22.42
10-year avg
-22.42
Hcmed’s PE Ratio is less than GlycoNex Incorporation (-12.30), less than Sunny Pharmtech Inc. (-7.45), greater than Advagene Biopharma Co., Ltd. (-23.47), less than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (-13.35), less than TaiRx, Inc. (-17.44), less than Genomics BioSci & Tech. Co.,Ltd. (-10.75), less than Steminent Biotherapeutics Inc. (-17.48), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (-37.07), less than Greenyn Biotechnology Co., Ltd (13.93), greater than Anti-Microbial Savior BioteQ Co., Ltd (-28.12),
| Company | PE Ratio | Market cap |
|---|---|---|
| -12.30 | $2.69B | |
| -7.45 | $2.01B | |
| -23.47 | $1.67B | |
| -13.35 | $1.91B | |
| -17.44 | $2.48B | |
| -10.75 | $1.79B | |
| -17.48 | $3.01B | |
| -37.07 | $2.60B | |
| 13.93 | $2.01B | |
| -28.12 | $2.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hcmed using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hcmed or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hcmed's PE Ratio?
How is the PE Ratio calculated for Hcmed (6934.TWO)?
What is the highest PE Ratio for Hcmed (6934.TWO)?
What is the 3-year average PE Ratio for Hcmed (6934.TWO)?
What is the 5-year average PE Ratio for Hcmed (6934.TWO)?
How does the current PE Ratio for Hcmed (6934.TWO) compare to its historical average?